therapy is different in Stx-associated childhood HUS as with swelling or detachment of the endothelial cell from compared with all the other forms of HUS and TTP [7] . the basement membrane, accumulation of fluffy material As well, simply for practical reasons, for all forms of in the subendothelial space, intraluminal platelet thromnon-Stx-associated HUS or TTP, the broader term HUS/ bosis, and partial or complete obstruction of the vessel TTP [8] will be used. lumina [2] . This lesion is common to various diseases [reviewed in 2]. Laboratory features of thrombocytopenia and hemolytic anemia are almost invariably pres-ROLE OF ENDOTHELIAL INJURY: ent in patients with TMA lesions, and reflect consump-AN OLD IDEA STILL IN PLACE tion and disruption of platelets and erythrocytes in the Most authorities consider endothelial injury as the cenmicrovasculature. Additional clinical signs depend on tral and likely inciting factor that sustains the microangiothe diverse distribution of the microvascular lesions and pathic process (Fig. 1) . This is not a recent idea, however.
As early as in 1942, Mark Altschule of Harvard Medical
Key words: Shigatoxin, endothelial activation, von Willebrand factor.
School suggested that microvascular endothelial activation was the primary event causing platelet deposition in arterioles and capillaries with secondary "clearance mice [12] . These findings were taken to indicate that a toxin possibly released by the microorganism could inof enormous numbers of platelets from the circulation" [9] . Actually, of the agents that have been associated duce hemorrhagic necrosis of the gastrointestinal mucosa and-once absorbed into the blood stream-of other with the disease in subsequent years, all are toxic to microvascular endothelium [reviewed in 2]. Moreover, organs. Several years later, Konowalciuck, Speirs and Stavric noted that E. coli isolated from human cases with plasma from patients with acute HUS/TTP induces apoptosis of human endothelial cells from the renal and diarrhea, produced a toxin similar to the one of Shigella cerebral microvasculature, but not from large vessels [10] .
dysenteriae type 1 (Shiga toxin or Stx) found cytopathic to Vero cells (African green monkey kidney cells) [13] . This toxin was subsequently given different names such
AGENTS IMPLICATED IN ENDOTHELIAL
as Shiga-like toxin (SLT), or verotoxin. In 1978, Koster ACTIVATION AND DAMAGE et al suggested that a circulating toxin was the cause of Shiga toxins colitis, hemolysis, and renal failure in children HUS with evidence of S. dysenteriae type 1 infection [14] . A few Despite that, the term HUS was introduced in 1954 [3] . A careful look at the older literature reveals some years later, a case-control study by Riley et al found a strong association between hemorrhagic colitis and ingesrelevant observations. In 1927, Adam first reported that an infant epidemiology of gastroenteritis was associated tion of E. coli O157:H7-infected beef patties at outlets of a well-known fast-food restaurant chain [15] . Recovery with a special type of bacterium coli, biochemically unique for its fermentation properties [11] . Subsequent observaof the same strain of E. coli (which could be readily distinguished from other fecal E. coli because of its unique tions described a similar disease with diarrhea, occasionally complicated by purpura, anuria, and neurological signs, inability to ferment sorbitol) from the stools of about half the 47 children with diarrhea, but from none of the healthy that was characterized at autopsy by capillary and arteriolar thrombosis and glomerular tuft occlusion by fibrin thrombi.
controls, suggested a cause-and-effect relationship between food-borne E. coli infection and hemorrhagic colitis [15] . E. coli serotype O111:B4 was considered the causative agent in more than 90% of these cases [12] . Further studies During the same period, Karmali et al demonstrated an increased Stx activity in fecal filtrates and increased Stxfound a filterable agent isolated from the stools of these children that caused diarrhea in calves and was lethal to neutralizing antibody titer in sera from children with E. coli O157:H7 infection and sporadic, diarrhea-associnever been detected in the circulation of patients with HUS. Of note, a very recent study found that, in vitro, Stx ated HUS [16] . Thus, almost 60 years after the seminal rapidly binds to polymorphonuclear leukocytes (PMNs), observations by Adams et al, these findings provided but not to erythrocytes, monocytes, platelets, or lipoprodefinitive demonstration of a direct role of a bacterial teins [24] . However, the Stx receptor on PMNs has a toxin (Stx) in the pathogenesis of HUS.
100-fold lower affinity than the high-affinity receptor Thus far, more than 100 E. coli serotypes have been (globotriaosylceramide or Gb3) expressed on glomerular found to produce Stx, but only few of them have been endothelial cells. As a consequence, at least in the in vitro involved in human disease. The serotype O157:H7 is by cocultures, PMNs loaded with Stx transfer the ligand to far the most common pathogen in the United States and glomerular endothelial cells, which promote cell death Europe, but other strains, particularly the O111:H-sero- [24] . Should this occur in vivo, it would explain the rapid type, are frequently reported in other areas of the world clearance of Stx from the circulation and its release to [17] . Of interest, E. coli O157:H7 strains that are isolated target organs where the toxin exerts its cytopathic effect. from patients with HUS usually produce both Stx-1 and Shiga toxins produced by S. dysenteriae type 1 and E. Stx-2 or only Stx-2. Of note, in a recent epidemy of Stx-1 coli comprise a family of multisubunit toxins that are struc-E. coli hemorrhagic colitis, no patient developed HUS, turally and genetically related. Shiga-like toxins (SLTs) suggesting that Stx-2 E. coli is the involved pathogen at are classified according to the extent of antigenic similarleast in most of the cases (abstract; Hashimoto H, et al, ity to Shiga toxin. SLTs whose cytotoxic activity is neuPediatrics 103:141, 1999) [18] .
tralized by antisera to Shiga toxin are referred to as type Escherichia coli O157:H7 colonizes healthy cattle in-1 (Stx-1), whereas SLTs that are not cross-neutralized testine, but also has been isolated from deer, sheep, goats, by anti-Shiga-toxin antibodies are classified as type 2 horses, dogs, birds, and flies [19] . It is found in manure, (Stx-2). Subtypes of Shiga-toxin 2 (Stx-2c and Stx-2e) water troughs, and other places in farms, which may share cross-hybridization of their genes under conditions explain the increased risk of infection observed in people of high stringency, but show significant differences in living in rural areas. The microorganism is transmitted biologic activity, serological reactivity, or receptor bindto humans by food and water, directly from person to ing [25] . All members of the toxin family consist of penperson [20, 21] and occasionally through occupational tamers of 7 to 8 kD binding subunits (B subunits) in exposure. Most food-borne outbreaks have been attribnoncovalent association with single enzymatic subunits uted to cattle-derived foods, in particular beef and raw (A subunits) of approximately 35 kD. They bind to target milk, although contaminated foods from other sources, cells via the neutral glycolipid Gb 3 and globotetraosylsuch as lamb and jerky, have been involved in some cases.
ceramide (Gb 4 ) and mediate protein synthesis inhibition Meat probably becomes contaminated at the time of in target cells by the specific N-glycosidase activity of A slaughter, and internalization of the microorganism dursubunits that act at a site adjacent to adenine-4324 in ing grinding may render it more likely to survive cooking. the 28 S rRNA component of eukaryotic ribosomes. Fruits and vegetables may also be contaminated, and
Human glomerular endothelial cells are sensitive to the radish sprouts, lettuce, apple cider, unpasteurized apple cytotoxic effects of Stx, particularly when exposure to juice, and alfalfa sprouts have been implicated in several tumor necrosis factor-␣ (TNF-␣) increases Gb3 expresoutbreaks. Water-borne outbreaks have occurred as a sion on cell surface and Gb3-mediated toxin binding and result of drinking and swimming in unchlorinated water.
internalization by endocytosis [26] . Gb3 fatty acid compoPerson-to-person transmission has been reported in daysition and phospholipid chain length within the phosphocare and chronic-care facilities [reviewed in 17] .
lipid bilayer also may play an important role in the intraAfter oral ingestion of contaminated food or water, cellular distribution and biological effects of the toxin. E. coli O157:H7 reaches the gut and closely adheres to For instance, Gb3 receptors containing shorter chain fatty the epithelial cells of the gastrointestinal mucosa. Adheacid species direct the toxin to the endoplasmic reticusion by a 97 kD outer membrane protein, intimin, prolum/rather than to the Golgi apparatus, and increase Stx duces characteristic "attaching and effacing" lesions aimed cytotoxicity [27] . Genetic differences in Gb3 fatty acid at preventing the expulsion of the microorganism [22] . composition might therefore account for different indiThe consequent disruption of the brush border per se is vidual susceptibility to the effects of Stx [27] . Inhibition sufficient to produce nonbloody diarrhea. In addition, of protein synthesis and cell death are the usual effects however, E. coli O157:H7 (as well as other Stx-producing of Stx. Sublethal Stx doses also may alter the production of serotypes such as E. coli O111, nonmotile O26:H11, or endothelial-derived vasoactive mediators such as endo-O103:H2) may produce large amounts of Stx, which trathelin and nitric oxide, which, in turn, might contribute to verse polarized gastrointestinal epithelial cells, probably the microvascular changes characteristic of hemorrhagic via transcellular pathways [23] who died from HUS secondary to pneumococcus pneuHowever, endothelial cells are not the only targets for monia and sepsis [35] . Binding studies also found weak Stx in the kidney, and several renal cell types (such as IgM deposits in the glomeruli indicative of a specific IgM proximal and distal tubular cells or mesangial and epithebinding to the Thomsen-Friedenreich antigen. Subsequent lial glomerular cells) have receptors for Stx and are damstudies demonstrated neuraminidase activity in organismaged by the toxin in vitro [30] . These findings suggest free filtrates of sera from three infants with Streptococcus that renal injury in Stx-HUS, unlike other forms of HUS/ pneumoniae-associated HUS, but not in filtrates of sera TTP, is not simply a consequence of vascular involvefrom a large series of samples from children with Streptoment in the microangiopathic process, but may reflect, at coccus pneumoniae infection and no evidence of HUS. least in part, a primary damage to parenchymal cells [30] .
Since the Thomsen-Friedenreich antigen is normally covExperimental evidence indicates that sites of Gb3 exered by N-acetyl neuraminic acid (sialic acid) moieties, pression coincide with sites of Stx-induced tissue damage it has been speculated that Streptococcus pneumoniae- [2] . Indeed, after a challenge with Stx-1 purified from E.
derived neuraminidase, by removing sialic acid from the coli O157:H7, rabbits presented neurologic and enteric cell membranes, exposes this cryptic antigen to preformed features of endothelial swelling and luminal occlusion circulating IgM antibodies [35, 36] . Then, IgM binding of small arteries and arterioles, but no signs of renal to Thomsen-Friedenreich antigen exposed on platelet and involvement [31] . Binding studies identified Stx recependothelial cell surface would cause platelet aggregation tors in the central nervous system and in the gastrointesand endothelial damage [35, 36] . Binding of IgM antibodtinal tract, but not in the kidney [31] . In humans, the ies to the antigen expressed on circulating erythrocytes Gb3 receptor is expressed not only in the kidney, but may explain why Coombs-positive hemolytic anemia is also on the membrane of epithelial and endothelial cells so frequently reported in patients with neuraminidaseof gastrointestinal mucosa and submucosa, respectively. induced HUS. Of interest, a recent study in baboons, which share with humans a similar distribution of gastrointestinal and reImmune complexes nal Gb3 receptors, demonstrated that Stx injection inComplement-dependent antibodies, which are cytoduces direct injury to the endothelial and epithelial cells toxic endothelial cells, have been found in the serum of the gastrointestinal and renal microcirculation [32] .
and plasma of patients with HUS/TTP [37] . Complement In this animal model, structural changes reminiscent of and IgG and IgM antibodies can be found in kidney biopthe autoptic changes observed in children with HUS and sies [2] . Together, these findings suggest a pathogenetic neurological involvement also were detected in the cenrole for immune complexes. This possibility is consistent tral nervous system, despite a relatively low expression with findings that endothelial cells exposed in vitro to of the Gb3 receptor in this organ [32] . Increased local sera of patients with HUS/TTP in the presence of comrelease of inflammatory mediators was advocated to conplement show ultrastructural changes of cytoplasmic intribute to renal tissue injury. This possibility is supported clusions and cytoplasmic and nuclear degeneration sugby the observation that neurological changes can be assogestive of endothelial cell apoptosis [37] . ciated with increased interleukin (IL)-6 concentration in Hemolytic uremic syndrome/TTP complicates immune liquor. Thus, the finding that, despite negligible Gb3 rediseases, in particular systemic lupus erythematosus, and ceptor expression, adult humans may develop central nerincreasingly is reported in association with the antiphosvous system lesions secondary to Stx-producing E. coli pholipid syndrome [reviewed in 38]. infection [20, 33] could be due to a facilitating effect of enhanced local release of inflammatory mediators [31, 32] .
Drugs Endotoxins
Several chemotherapeutic agents, including mitomycin C (MMC), cisplatin, daunorubimicin, cytosine arabiUpon E. coli infection, bacterial-derived endotoxins noside, chlorozotocin, neocarcinostatin, and deoxycofor-(lipopolysaccharides or LPS) and Stx act synergetically mycin, have been implicated in a syndrome of thrombotic in initiating damage to target organs, including the kidmicroangiopathy designated as chemotherapy-associney. LPS prime the endothelial cells to undergo apoptoated HUS (C-HUS) [reviewed in 39]. MMC causes TMA sis when exposed to picomolar amounts of Stx. Moreafter direct infusion into rat kidneys. Endothelial cells over, LPS derived from Stx producing E. coli activate metabolize MMC to a reactive intermediate that crossPMNs to release TNF-␣, IL-1, elastase, and free radicals that are highly toxic to microvascular endothelium [34] .
links cellular DNA and proteins. Endothelial cells, ex-posed to MMC in vitro at concentrations equivalent to CONSEQUENCES OF VASCULAR INJURY therapeutic drug levels in vivo, survive but subsequently Virtually all properties of the normal microvascular show both an impaired ability to divide and a reduced endothelium are altered in HUS/TTP. Endothelial cells thrombin-stimulated production of prostacyclin.
synthesize many substances involved in coagulation and Cyclosporine. Cyclosporine A (CsA) has been associfibrinolysis, including prostacyclin, nitric oxide (NO), ated with de novo thrombotic microangiopathy in renal vWF, thrombomodulin, tissue-type plasminogen activaand nonrenal transplantation and in patients with Behtor inhibitor and protein S. Loss of prostacyclin [47] and çets disease [40] . Thrombotic microangiopathy in renal increase in vWF [48] have been claimed to account for allograft recipients is most common in the first weeks, the loss of physiologic thromboresistance and for the when CsA drug levels are highest, and should be differconsequent widespread platelet aggregation in vascular entiated from both humorally and/or cell-mediated rejecbeds throughout the body, creating a cycle of vasocontion. In renal allograft recipients, CsA enhances platelet striction with platelet and fibrin deposition and further aggregation and thromboxane A 2 production, and high thrombus formation. CsA levels correlate with increased thrombomodulin and von Willebrand factor serum levels. Since the first Leukocyte activation and complement consumption report by Schmidt et al in 1991, more than 20 cases have
The interaction between leukocytes and damaged enbeen described providing evidence that tacrolimus may dothelial cells is instrumental to the development of micause HUS/TTP [41, 42] . The disease is reported in 1 to crovascular injury in Stx-associated HUS, as documented 4.7% of tacrolimus treated patients. It is more frequently by experimental and clinical evidence [34] . Neutrophils diagnosed in the first year after transplantation, although from children in the acute phase of HUS adhere to endoit may occur at any time.
thelial cells in vitro more tightly than normal neutrophils Ticlopidine and clopidogrel. Ticlopidine has been assoand induce endothelial injury by degrading endothelial cell ciated with the development of HUS/TTP, but this event fibronectin, possibly by the release of neutrophil-specific is rare (1 in 1600 patients treated with ticlopidine after proteases [34] . Stx in vitro promotes massive leukocyte cardiac stenting) [43] . Clopidogrel, a new antiplatelet adhesion and transmigration to endothelium under flow agent that has achieved widespread clinical acceptance conditions by up-regulating endothelial expression of adbecause of a more favorable safety profile than ticlopihesive proteins and chemokines (abstract; Zoja et al, dine, also has been associated with the disease, and 11 J Am Soc Nephrol 10:595A, 1999). Platelet and leukocyte cases have been reported recently [44] . Ten of these activation concur to promote the formation of C3bBb patients developed TTP within two weeks from beginconvertase, which in turn leads to cleavage of the third ning the drug treatment. Ticlopidine and clopidogrel are fraction of complement (C3) to the active form C3b, structurally related derivatives of thienopyridine and act ready to react with any cell surface or membrane nucleoby blocking an adenosine diphosphate-binding site on phile. Low C3 levels were first described in diarrheaplatelets, which inhibits the expression of the glycoproassociated HUS in the early 1970s [49] . Persistently low tein IIb/IIIa receptor in the high-affinity configuration complement levels were found in different forms of HUS that binds fibrinogen and large von Willebrand factor [49] . Granular C3 deposits in glomeruli and arterioles of (vWF) multimers. Why these two drugs cause TTP is patients with either diarrhea-associated or adult forms not fully clear, but of great interest, as patients with of HUS/TTP and evidence of C3 breakdown products ticlopidine-or clopidogrel-associated TTP have a defiin patients' sera were taken to reflect complement conciency of vWF-cleaving protease activity in plasma that sumption in the microvasculature [50] . appears quite comparable to the deficiency observed in idiopathic TTP [44] .
Abnormal von Willebrand factor Quinine. Quinine is widely used for the prophylaxis release and processing of nocturnal cramps, but is also present in tonic water and
In normal individuals, vWF is formed as large multibitter lemon drinks. Occasionally, it may cause hemolytic mers [ultralarge (UL) multimers] due to the polymerizaanemia, thrombocytopenia, disseminated intravascular tion in endothelial cells and megakaryocytes of a native coagulation, and HUS [45] . HUS typically occurs in pasubunit with an apparent molecular mass of 225 kD, and tients presensitized by prior exposure to quinine and is stored as such in Weibel-Palade bodies and platelet rapidly follows re-ingestion of the compound. by plasma therapy was concurrent with an almost full its activation, is inhibited by calcium-chelating agents, recovery of the vWF-cleaving protease activity. Both and is activated only in conditions of low ionic strength patients achieved a long-lasting remission, although proor high shear stress. In vivo evidence that proteolytic tease activity decreased to less than 20% over 20 days cleavage is involved in the modification of plasma multiafter plasma therapy withdrawal. mers after secretion has been provided by studies showIn nonfamilial cases, the protease deficiency appears ing that circulating vWF multimers are heterogeneous to be a consequence of a specific autoantibody that develoligomers of a native 225 kD subunit and of proteolytic ops transiently and tends to disappear during remission fragments with apparent molecular masses of 189, 176, [51] . In a patient with recurrent episodes of TTP shown to and 140 kD [53] . In patients with HUS and TTP, in conhave an acquired inhibitor of the vWF-cleaving protease trast to healthy subjects, UL multimers similar to the
[60], splenectomy, performed one year after the first TTP ones stored in endothelial cells and platelets were occaevent, resulted in the disappearance of the autoantibody sionally detected in plasma [54] . The presence in patients and normalization of the protease activity, platelet count, with HUS/TTP of circulating UL multimers that in vitro and hemoglobin levels [60] . are capable of supporting platelet aggregation more effiAt variance with TTP, in the previously mentioned ciently than normal multimers was evidence for their studies, no deficiency was found in patients with familial pathogenic role in microvascular thrombi [55] . However, or sporadic forms of HUS [51] , suggesting that the presdirect proof that this was indeed the case was never proence or absence of this activity were enough to classify vided. Interestingly, the opposite appears true in vivo, patients as having HUS or TTP, respectively. More recent since the available evidence is against the possibility that data, however, indicate that low or zero protease activity UL vWF multimers when present in the circulation can is not confined to TTP and can even be found in a number even cause intravascular thrombosis. UL multimers have of diseases associated with an increased tendency to thrombeen found in fetuses and newborns, but disappear within bosis, such as inflammatory states, liver cirrhosis, major the first months of life, indicating that physiologic cleavsurgery (Mannucci et al, personal communication, Workage of vWF is less efficient at birth and fully develops shop on vWF and TTP, Bethesda, July 31, 2000), and later in life [56] . Moreover, in patients with a rare variant disseminated malignancies [7] . Another child who was of von Willebrand disease, named "Vicenza," UL vWF diagnosed as HUS/TTP, although he had renal failure multimers were constantly found in the circulation; noneand no neurological symptoms, showed with zero vWF theless, these patients never experienced thrombotic epiprotease activity [61] . Our group has obtained similar sodes; rather, they suffered with bleeding tendency [57] .
results of complete lack of protease in two cases of recurIn patients with HUS/TTP who recovered after a sinrent HUS (unpublished results). These data indicate that gle episode, UL multimers were found almost exclusively the issue is controversial and the distinction between in the acute phase but not in remission, suggesting a mas-HUS and TTP is much more complicated than presented sive release from storage sites of acutely injured endothein the New England Journal of Medicine articles [51, 52] lial cells that possibly transiently overwhelmed the and accompanying editorial [55] . plasma proteolytic capacity [58] . In contrast, those cases A constant finding in the acute phase of different forms that had a tendency to recur had circulating UL multiof HUS/TTP is an increase of low molecular weight mulmers either in the acute phase or consistently in the timers and a decrease of high molecular weight multiremission phase of the disease, which was initially taken mers, which reflects an enhanced proteolytic fragmenas evidence of a state of persistent endothelial perturbatation of the molecule [62, 63] . That vWF undergoes tion [54] . The hypothesis that circulating UL vWF multiexcessive fragmentation in the acute phase of these dismers may reflect a condition of endothelial perturbation eases is remarkably consistent with previous findings of has been recently challenged by findings that circulating a relative decrease in the native 225 kD vWF subunit, UL multimers in chronic relapsing TTP were associated which only occurs in the acute phase, accompanied by with a reduced or totally absent activity of the above a relative increase of fragments that can only derive from vWF-cleaving protease activity that normally cleaves vWF the cleavage of the native subunit [64] . multimers to smaller molecular forms. In two large studies, vWF-cleaving protease deficiency was described in Enhanced vascular shear stress as a determinant of patients with different forms of TTP [51, 52] . In familial abnormal von Willebrand factor fragmentation forms of TTP, the deficiency is probably inherited as an von Willebrand factor's susceptibility to fragmentation autosomal recessive trait. Consistent with this possibility, increases in response to rising levels of shear stress [65] , complete deficiency of vWF-cleaving protease activity which induces protein unfolding and makes vWF proteowas found in two brothers with chronic relapsing TTP, whereas their parents had approximately half-normal prolytic cleavage sites more accessible to specific plasma protease(s). It is speculated that enhanced shear stress of acute disease, and only two had moderately increased LDH levels [67] . in the severely narrowed damaged microvessels accounts for the abnormal vWF fragmentation observed during Actually, low C3 levels are well known to accompany the acute phases either of diarrhea-associated or idiothe acute phase of HUS/TTP. Evidence of increased capacity of fragmented vWF to bind receptors on actipathic HUS [49] and likely reflect C3 consumption in the microvasculature. Granular C3 deposits in glomeruli vated platelets suggests that shear stress-induced vWF fragmentation may contribute to maintain and further and arterioles of HUS patients [50] and evidence of C3 breakdown products in HUS sera [49] further document spread microvascular thrombosis. In severe forms of HUS that are resistant to plasma therapy, removal of the activation of the complement system in the acute phase of the disease. Enhanced release of complement the kidneys-a major site of vascular bed occlusion and augmented shear stress-was followed by hematologic cleavage products (including C3a and C5a) consequent to uncontrolled complement activation may contribute and clinical remission associated with restoring the vWF fragmentation pathway to normal [62] . Consistent with to the microangiopathic process by stimulating neutrophil activation phagocytic adhesion to vascular endothethis possibility in patients with recurrent and sporadic HUS/TTP, increased vWF fragmentation normalized lium, or platelet aggregation, and by directly injuring the endothelium through enhanced production of the memafter resolution of the microangiophatic process.
brane attack complex, the final multimolecular unit of the complement C5b-9.
GENETIC PREDISPOSITION
Two complement pathways can generate C3-activating Congenital complement abnormalities enzymes: the classic convertase generated by the sequential reaction of C1, C4, and C2, and the alternative pathOver the last 20 years, approximately 140 cases of familial HUS and TTP have been described in 70 famiway convertase. Activation of classic and alternative complement pathway-possibly triggered by circulating lies, with the predominant features of HUS in two thirds of the patients. Both autosomal-recessive and autosomalimmune complexes and damaged erythrocytes, respecdominant modes of inheritance have been recognized [66] .
tively-is well documented in acute HUS [68] , but consisPrecipitating events such as pregnancy, virus-like distently subsides with remission of the disease. In contrast, ease, or sepsis have been reported only in a minority of in cases of familial HUS/TTP, serum C3 levels were consiscases. Evidence that some of these cases responded, at tently and remarkably depressed in cases as compared least transiently, to plasma infusion or exchange, sugwith controls, even during remission of the disease [67] . gests that the genetic defect(s) associated with familial Even more interestingly, low C3 levels also were found HUS/TTP were the cause of one or more abnormalities in the patients' relatives, who had never suffered with in plasma component(s) essential to the integrity of mi-HUS or TTP in the past and had no sign of the disease crovascular circulation and/or to the defense mechanism at the time of the study [67] . Furthermore, either in cases of the host endothelium against injurious agents. Thus, or in case-relatives depressed C3 values did not parallel reduced serum levels of the third component (C3) of the similar changes in C4 levels. These data definitely ruled complement system have been reported since 1974 [49] out the possibility that classic pathway activation acin both the sporadic and familial forms of HUS [67] . That counted for hypocomplementemia in this series [67] . An the disease may be related to an inherited congenital inherited defect in C3 synthesis has been suggested to abnormality is consistent with the finding that more than account for decreased C3 serum concentration [67] , but 50% of patients with familial HUS/TTP-as compared much more convincing data are now available that low with only 10 to 20% in nonfamilial forms-had repeated C3 in HUS may derive from either a lack or altered function recurrences. This genetical abnormality is likely to inof factor H, a regulatory protein that inhibits the complevolve the complement system, as suggested by levels of ment activation through the alternative pathway [69] . circulating C3, which were extremely low in a large series of familial cases as compared with controls [67] . Reduced INHERITED FACTOR H DEFICIENCY C3 levels in cases and case relatives, but not in controls
In one patient with HUS and in his healthy brother, and the controls' relatives, further indicate that the dea persistent reduction in C3 levels was found with very fect clusters in families. Evidence that a low C3 concenlow levels of factor H [70] . Finding that the parents, who tration was strongly associated with the disease even were first cousins, had half-normal levels of factor H, more convincingly suggests the possibility of a tight (posconvincingly indicated that the defect was inherited. A sibly causal) relationship between decreased C3 and dissimilar finding was later reported in another family. In ease manifestation [67] . On the other hand, in the prea recent report, the association between inherited factor viously mentioned series, low C3 levels could not depend H deficiency and low C3 levels was investigated in a on consumption in a still-ongoing microangiopathic process, since no patient at the time of the study had any sign large series of families with a history of HUS/TTP [67] .
By radial immunodiffusion and Western blot analysis, a C to G transversion causing an arginine to glycine change two affected subjects of one family were identified who in the short consensus repeat 20 (SCR20) [72] . This mutahad very low circulating factor H levels, and moderately tion is likely to alter structure and hence function of low levels were found in two healthy relatives. In these factor H protein without modifying its circulating levels. patients, the cofactor activity of factor H, measured as The same authors also described a nonsense mutation, the capacity to degrade C3b, was also reduced. In the located in SCR1 of factor H gene, in a single case with other families, serum factor H concentration was normal late onset [72] . In a large series of patients, four new [67] ; however, normal serum levels do not necessarily heterozygous mutations in factor H gene were found exclude an underlying biochemical abnormality in circu- [73] . Three of the mutations were observed in families lating factor H. In this regard, in another family the with dominant transmission, the fourth was found in a two affected members, and the healthy father, who had single case who experienced disease recurrence on the normal serum concentrations of factor H by radial immurenal allograft. Loirat et al have recently reported five nodiffusion, Western blots showed additional bands of cases of atypical HUS with neonatal onset and 2 to 15 higher molecular weights that were not found in any relapses over 2 to 14 years follow-up, who had complete controls [67] . The bands might represent dimeric forms and persistent vWF-cleaving protease deficiency (abstract; of factor H. At variance, no differences were found in Loirat et al, Twelfth Congress of the International Pediserum levels and patterns of FHL-1 and FHR proteins atric Nephrology Association, Seattle, WA, USA, Sep- [69] . Similar results were obtained in another series of tember 1-2, 2001) [74, 75] . Another study reported an patients with HUS [71] . apparent mutation in factor H (a C to T transition in Factor H has several biological activities. It prevents SCR 20) in a family with HUS with a recessive mode of the formation of C3bBb complex and accelerates the inheritance and severely depressed factor H levels [76] . dissociation of Bb from the C3 convertase. It acts as a However, two independent groups subsequently procofactor for factor I that degrades C3b [69] , and it also vided evidence that the apparent mutation was actually distinguishes between activator and nonactivator suran artifact caused by coamplification of a factor H-related faces [69] . Other less well-defined functions of factor H gene, and demonstrated that the real mutation in this have been suggested by the presence of at least two family is an A to T transversion and a 24 bp deletion heparin binding sites in factor H protein that could facilithat was present in homozygosity in affected members tate interaction with extracellular matrix [69] . An interpatients and in heterozygosity in the healthy carriers current exposure to agents potentially toxic to the vascu-(abstract; Caprioli et al, J Am Soc Nephrol 11:404A, lar endothelium (such as certain virus, bacteria, toxins, 2000) [77] . Altogether, the available data provide comimmunocomplexes, and cytotoxic drugs [2]) may initiate pelling molecular evidence that genetic alterations in faca local intravascular thrombosis, which promotes C3bBb tor H are involved in both autosomal dominant and recesconvertase formation and complement deposition within sive HUS. Data that followed exposure to SLT producing capillary vessels. In normal conditions, however, by mod-E. coli, where only 2 to 7% of the patients progressed ulating C3bBb activity factor H may effectively limit to overt HUS, suggest that a genetic predisposition also complement deposition and further extension of the promay have a role in the typical diarrhea-associated forms. cess [69] . In contrast, when the bioavailability and/or Polymorphisms in the promoter and in the coding regions activity of factor H is congenitally defective, C3bBb conof the factor H gene have been recently described. It is vertase formation and complement deposition may beintriguing to speculate that some of these polymorphic come uncontrolled, with further extension of the microvariants confer a genetic predisposition to SLT-induced angiopathic process up to full manifestation of the disease.
HUS. Although it seems clear that familial HUS is related to an inherited congenital defect, the cause of the GENE MUTATIONS ACCOUNTING FOR syndrome is probably multifactorial and the inherited FACTOR H DEFICIENCY OR ABNORMALITIES complement defects simply may represent a predisposing condition that increases the risk of the disease in combiThe consistent association found in families between nation to other intercurrent environmental or acquired factor H abnormalities and low C3 levels supports the factors. Thus, in a family with hereditary hypocomplemhypothesis that low C3 in the setting of familial HUS/ entemia, only one of the six members with low C3 levels TTP may depend on a genetic deficiency of factor H.
developed HUS, apparently following a flu-like episode A recent report on three large families with HUS [67] . It is also possible that genetic defects in other comdocumented that an area on chromosome 1q, where facplement regulatory proteins (DAF, CR1, CR2, C4bp) tor H is mapped, segregates with HUS [72] . All subjects might have a role in determining low C3 in familial HUS in the three families had normal serum factor H levels.
and TTP. Data support this possibility that the above However, affected members and obligate carriers within genes map on the same region of chromosome 1q as one family were found, by mutation analysis, to have a heterozygous point mutation in factor H, consisting of factor H [78] . . Regardless of the renal characterized by prodromal diarrhea followed by acute damage, however, in the long term, 10 to 42% of children renal failure. The overall incidence is estimated to be have some renal sequelae (such as proteinuria and/or mod-2.1 cases per 100,000 persons/year with a peak incidence erate hypertension or mildly reduced GFR), 10 to 22% in children younger than five years of age (6.1/100,000/ have chronic renal failure, and 2 to 9% ESRD) [81, 82] . year) and the lowest rate in adults 50 to 59 years old Neuraminidase-associated HUS. This is a rare but po-(0.5/100,000/year) [79] .
CLINICAL FEATURES OF THE DIFFERENT
tentially fatal disease that may complicate pneumonia, E. coli O157 infection is most common in the warm or less frequently, meningitis caused by Streptococcus summer months. The average interval between Stx-E. coli pneumoniae [35, 36] . The clinical picture is usually severe, exposure and illness is three (range of 1 to 8) days [17] .
with respiratory distress, anuria, neurological involveIllness typically begins with abdominal cramps and nonment, and coma. bloody diarrhea; diarrhea may become hemorrhagic in Idiopathic or atypical HUS. This is a subgroup with 70% of cases usually within one or two days. Vomiting unknown etiology and no seasonal pattern that differs occurs in 30 to 60% of cases and fever in only 30%.
from Stx-associated HUS on epidemiologic, clinical, labSerum leukocyte count is usually elevated, and a barium oratory, and prognostic grounds. The onset is usually insidenema may demonstrate "thumb-printing," suggestive ious, without antecedent diarrhea, and may be preceded of edema and submucosal hemorrhage, especially in the by nephrotic syndrome. The disease occasionally is familregion of the ascending and transverse colon. Superficial ial, has a tendency to relapse, and carries a worse prognoulcerations or pseudomembranes are common. E. coli sis than Stx-associated HUS [83] . Upper respiratory tract O157 infection is complicated by HUS in 3 to 7% of the infection may trigger the disease in approximately 30% sporadic cases and up to approximately 20% or more of of cases [83] . The clinical syndrome resembles TTP. Onethe epidemic forms [17] . HUS is usually diagnosed six third of these patients have central nervous system days after the onset of diarrhea. After HUS infection, involvement at onset, with convulsions and alterations Stx-E. coli may be shed in the stool for several weeks of consciousness that persist despite correction of hyperafter the symptoms are resolved, particularly in younger tension and metabolic complications of renal failure. The children (Ͻ5 years age) who in one-third of the cases may outcome is severe [83] [84] [85] . carry the organism for over 20 days. Use of antimotility Adult HUS/TTP agents and antibiotics, bloody diarrhea, fever, vomiting, elevated serum leukocyte count, extremes of age (in STX-associated HUS/TTP. Albeit less frequently than particular children Ͻ5 years old), and female sex have in children, Stx HUS has been reported even in adults, been associated with an increased risk of HUS following either in epidemics involving elderly people in nursing Stx-E. coli infection [17] .
homes or in sporadic cases [20, 33] . The etiology and Fifty percent of patients who develop HUS need dialpathogenesis of childhood and adult Stx HUS are the ysis, 75% require red blood cell transfusions, and 25% same, but renal and neurological involvement are usually have neurological signs, including stroke, seizure, and more severe and sequelae more frequent in adults than coma [17] . Stx-associated HUS is erroneously regarded in children [86] . Indeed, in older patients, a mortality rate as a benign disease. Indeed, 3 to 5% of children die in close to 90% has been reported, a figure that is at least the acute phase and a similar percentage develop end-10-to 20-fold higher than in pediatric series [20, 33, 86] . stage renal disease (ESRD) [80] . Moreover, long-term Acute idiopathic HUS/TTP. The defining clinical feasequelae are common. In a series of 88 children, Fitzpatures include thrombocytopenia, microangiopathic hetrick et al reported long-term renal dysfunction in 39% molytic anemia, neurological and renal abnormalities, of cases, a residual glomerular filtration rate (GFR) Ͻ80 and fever. Neurological symptoms usually dominate the mL/min 173 m 2 in 18%, and persistent microalbuminuria clinical picture, but usually subside within 48 hours after in 31% [81] . In different series, the incidence of ESRD initiation of plasma therapy [7] . Clinical response and ranged from 3 to 18% [17] . The duration of anuria is a survival are comparable in patients with and without strong predictor of residual renal dysfunction. Indeed, renal failure [5, 6] . only 4 of 53 children (7.5%) with a duration of anuria Relapsing and frequently relapsing HUS/TTP. Relapsing forms are increasingly reported [87, 88] , as more less than ten 10 days were found to have a residual GFR fluffy material in the subendothelium. These changes are patients than in the past recover from the initial acute virtually identical and often indistinguishable from the episode thanks to improved supportive and specific treatmicrovascular lesions of scleroderma and malignant hyments. An extremely rare variant of relapsing HUS/TTP, pertension [2] . In HUS, the microthrombi are confined also known as "chronic relapsing" or "frequent relapsprimarily to the kidneys (Fig. 2) , and thus, renal failure ing" HUS/TTP, is characterized by frequent episodes, is the dominant feature. TTP mainly involves the brain, recurring after symptom-free intervals of a predictable and intravascular thrombi apparently form and disperse duration ‫1ف(‬ month in most cases) [89] .
repeatedly, producing intermittent neurological signs. In pediatric patients, particularly in children younger than FAMILIAL HUS/TTP two years of age and in most cases of Stx-associated HUS, This form has a heterogeneous pattern of inheritance a pattern of glomerular injury is prominent (Fig. 2) . Leuand presents as HUS or as TTP in several members of kocyte infiltrates and thrombi are common during the a given family. Less frequently, it may present as HUS early phases of the disease and usually resolve over two in some and as TTP in other members of the same family.
or three weeks. Later on, renal biopsies show ectatic gloThese are cases in which the disease had different clinical merular capillaries, swollen endothelial cells, and some depresentations in the same individual, with some episodes gree of necrosis. Patchy cortical necrosis may be seen in more reminiscent of HUS and others of TTP [67] . Demore severe cases; crescents are uncommon. Predomicreased factor H bioavailability and abnormalities in vWF nant arteriolar involvement, with intimal proliferation and handling may have an important pathogenetic role in hyperplasia, and secondary glomerular ischemia and colfamilial forms (see paragraph "Genetic predisposition").
lapse are frequently found in idiopathic and familial forms Genetic counseling is important if pregnancies are planned.
and in older children (Figs. 3 and 4) [2]. Prognosis is good The outcome is usually poor with death or chronic renal in cases with predominantly glomerular changes, but is failure being reported in 50 to 100% of cases [66] and much more severe in those with primarily vascular dampost-transplant recurrences in about 50% of cases [90] . age ( Pure glomerular involvement is uncommon in adults. Thrombocytopenia is usually severe, with platelet counts Vascular involvement is the predominant finding and is associated with more severe hypertension, more frequent below 60,000/mm 3 in most cases. Platelet survival time neurological involvement, higher risk of renal and neurois reduced, reflecting enhanced platelet disruption in the logical sequelae, and higher mortality [92] . For instance, circulation. Giant platelets may be seen in the peripheral in 20 consecutive patients, Morel-Maroger reported only smear, a finding consistent with secondary activation of two cases with almost pure glomerular involvement who thrombocytopoiesis.
completely recovered [92] . None of the remaining 18 Anemia is usually severe, hemoglobin levels less than patients in her series recovered. Ten died, four pro-10 mg/dL being reported in 99% of cases and less than gressed to ESRD, and four had residual chronic renal 6.5 mg/dL in 40% of cases. Serum lactate dehydrogenase insufficiency and hypertension. (LDH) levels are increased, often at very high levels, reflecting not only hemolysis, but also diffuse tissue isch-TREATMENT GUIDELINES emia [91] . Hyperbilirubinemia (mainly unconjugated), Childhood Stx-E. coli-associated HUS usually recovreticulocytosis, circulating free hemoglobin, and low or ers spontaneously and does not require plasma therapy undetectable haptoglobin levels are additional aspecific [7] . In contrast, a general consensus has been achieved indicators of the accelerated red cell disruption and prothat plasma exchange or infusion should always be tried duction. Indeed, detection of fragmented red blood cells in adult HUS/TTP to minimize the risk of death or long-(schistocytes) with the typical aspect of burr or helmet term sequelae (Table 1 ) [7] . The outcome of secondary cells in the peripheral smear together with a negative forms, instead, mainly depends on the prognosis of the Coombs test (with the exception of streptococcus pneuunderlying condition. Platelet count and serum LDH are moniae-associated HUS [35, 36] ) are needed to confirm the most sensitive markers for monitoring the response the microangiopathic nature of the hemolysis.
to plasma therapy. Treatment should be continued until PATHOLOGY complete disease remission is achieved [7] . However, no clinical parameter predicts the duration for plasma The characteristic histologic lesion of HUS and TTP therapy. The decision to stop or continue plasma therapy consists of vessel wall thickening (capillaries and arteriis empirical. Prompt exacerbation of disease activity, prinoles), with swelling and detachment of the endothelial cells from the basement membrane and accumulation of cipally manifested by a falling platelet count and requir- ing the resumption of daily plasma therapy, is common from 40 to 50% to the current 3 to 5%-probably as the result of better supportive management of anemia, renal after treatment discontinuation with reported frequencies of 29 to 82% [5, 7, 93] . Of course, this mandates failure, hypertension, and electrolyte and water imbalance [79] . However, no specific therapy aimed to prevent additional treatment. Actually, discontinuation of plasma therapy is the only way to know whether a durable remisor limit the microangiopathic process has been proven to affect the course of the disease in children. Antimotility sion has been achieved, and many cycles of stopping and resuming plasma therapy may be required.
agents may increase the risk of toxic megacolon. Antibiotics given to treat infection due to Stx-producing E. coli O157:H7 have been found to increase the risk of CHILDHOOD HUS overt HUS by 17-fold [94] . Indeed, antibiotic-induced STX-associated HUS injury to the bacterial membrane might favor the acute release of large amounts of preformed toxin. AlternaIn typical Stx-associated HUS in children, the mortality rate has significantly decreased over the last 40 yearstively, antibiotic therapy might give E. coli O157:H7 a . In partype 1 [96] . For instance, when hemorrhagic colitis is caused ticular, no prospective, randomized trials are available to by S. dysenteriae type 1, early and empirical antibiotic definitely establish whether plasma infusion or exchange treatment shortens the duration of diarrhea, decreases may offer some specific benefit as compared to supportthe incidence of complications, and reduces the risk of ive treatment alone. However, comparative analyses of transmission by shortening the duration of bacterial shedtwo large series of patients treated [33] or not [20] with ding [97] . Thus, in developing countries where Shigella is plasma suggest that plasma therapy may dramatically the most frequent cause of hemorrhagic colitis, antibiotic decrease overall mortality of Stx-E. coli O157:H7-associtherapy should be started early and even before the inated HUS. These findings lead others and us to consider volved pathogen is identified [96] .
plasma infusion or exchange indicated in adult patients, New agents targeted to prevent organ exposition to in particular in those with severe renal insufficiency and Stx are currently under evaluation. The most promising central nervous system involvement [6, 7] . are Synsorb-PK, a resin composed of repeated synthetic Acute idiopathic HUS/TTP. Plasma manipulation is a carbohydrate determinants linked to colloidal silica that cornerstone in the therapy of acute idiopathic HUS/TTP. binds Stx; recombinant modified E. coli that displays a Exchange has been claimed to be superior than to plasma Stx receptor mimic on its surface and adsorbs and neutralinfusion in one study [5] . However, patients treated with izes Stx with very high efficiency; and "STARFISH," an exchange were given larger amounts of plasma than those oligovalent, water-soluble carbohydrate ligand that can treated with plasma infusion alone. Indeed, when equivasimultaneously engage all five B subunits of two toxin lent volumes of plasma were given, infusion and exchange molecules. These approaches offer potent new weapons appeared to be equally effective [100] . Plasma exchange against Stx-E. coli-induced hemorrhagic diarrhea and should be considered as first-choice therapy when renal HUS. Oral administration of Synsorb or recombinant insufficiency or heart failure limit the amount of plasma modified E. coli could efficiently clear toxin from the that can be provided with infusion alone. Cryosupernagut, whereas intravenous administration of "STARFISH" tant fraction (that is, plasma from which a cryoprecypimight help to prevent toxin that already has entered the tate containing the largest plasma vWF multimers, fibrincirculation from destroying kidney function and microogen, and fibronectin has been removed) instead of fresh vessels. Preliminary analyses of an ongoing trial in Canfrozen plasma has been successful in treating a small ada found that early treatment (within two days after number of patients who did not respond to repeated exthe onset of diarrhea) with Synsorb-PK decreased the changes or infusions with fresh frozen plasma [101] . The risk of HUS from 17 to 7% [98] . Toxin-neutralizing antirationale for this approach is that plasma cryosupernabodies might be a future possible prevention for E. coli tant may provide the same beneficial factor(s) found in infection. Actually, natural infection with E. coli O157 whole plasma, but does not contain those factors (includdoes not confer immunity, and no human vaccine is curing large vWF multimers) that may actually sustain the rently available. Nevertheless, Shiga toxoid vaccines have microangiopathic process until remission is achieved. On been shown to be effective in preventing related diseases the basis of the previously mentioned information, the in animals. Generalized pasteurization of ground beef use of plasma cryosupernatant has been suggested as first through irradiation will further help to limit/prevent E.
line therapy of adult HUS/TTP. However, results of the coli O157 and other food-borne pathogen infections.
few small, randomized studies failed to find differences Neuroaminidase-associated HUS. The role of plasma between the two products. therapy is controversial. In theory, whole blood and Usually one plasma volume (40 mL/kg) is exchanged plasma should be avoided, since they contain IgM and per session. Treatment can be intensified by increasing may accelerate polyagglutination and hemolysis through the volume of plasma replaced. The twice-daily exchanges IgM-mediated erythrocyte and endothelial cell injury of one plasma volume is probably the treatment of choice [99] . Thus, patients should be treated only with antibiotfor refractory patients in order to minimize the recycling of infused plasma [7] . Serum LDH and platelet count ics and washed red cells [36] . In some cases, however, are the most reliable markers of response, and plasma recover with delivery, and plasma therapy should be therapy should be continued until they are persistently restricted only to cases at imminent risk of death or with normalized. Occasional patients with idiopathic HUS/ no evidence of disease recovery over 24 to 48 hours after TTP do not achieve remission despite plasma therapy.
delivery [103] . Cases occurring earlier in the course of Some of them become plasma-dependent and require gestation are usually episodes of acute, idiopathic HUS/ continued treatment, since disease relapses as soon as TTP and are best treated with plasma therapy. Those plasma infusion or exchange is stopped. Splenectomy occurring after a normal delivery are usually defined as has been found to induce remission in some plasmapostpartum HUS. The pathogenesis is unclear, and the resistant cases, but was ineffective and actually increased outcome is usually poor with a high incidence of renal morbidity and mortality in others [93] . Recently, the sequelae even despite aggressive plasma therapy. Cases presence in the circulation of autoantibodies against recurring after a kidney transplant are almost invariably vWF-cleaving protease has been claimed to help identify found in the context of a familial or recurrent background patients who may benefit of glucocorticoid or vincristine and are usually associated with a poor outcome [90] . treatment, removal of IgG by immunoadsorption on proQuite different is the outcome of de novo post-transplant tein A, or splenectomy [51] .
HUS that may be associated with CsA or tacrolimus Consistent data are available on the beneficial effect therapy or with vascular rejection. Removal of the drug of bilateral nephrectomy, in particular in patients with and effective treatment of the rejection, plus plasma severe renal involvement, refractory hypertension, and therapy, can cure the disease. signs of hypertensive encephalopathy [62] . Combined to plasma therapy, antiplatelet agents have no additional ACKNOWLEDGMENTS effect on the outcome of the disease [5, 93] . The same
